Home › Cancer (all types) › NCT07433660
WellSpan-THRIVE Cancer QOL Study
WellSpan Study of Tracking Health and Resilience to Improve the Vitality of Individuals Experiencing Cancer [WellSpan-THRIVE]
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Age 18 years and above * Primary cancer diagnosis (newly diagnosed within the past 6 months) * Able to sign informed consent. Exclusion Criteria: * Patients with age\<18 years, * Patients with primary non-melanoma skin, neurological malignancies (Brain or brain metastases), and primary hematological malignancies. * Patients with severe cognitive impairment, unable to sign informed consent or unable to complete quality of life questionnaire. * Patients with life expectancy of \<90 days, in the opinion of treating investigator.
About the study
Cancer affects millions of people worldwide and can significantly impact not only survival, but also day-to-day quality of life. Treatments such as surgery, chemotherapy, and radiation can cause side effects like fatigue, pain, and neuropathy, which may affect physical function, emotional well-being, and social relationships. While many studies have examined factors that influence quality of life; such as age, type and stage of cancer, and treatment-related symptoms; there is still a need for tools that more fully reflect patients' lived experiences.
This study aims to develop and implement a patient-centered quality of life (QOL) survey designed specifically for individuals with cancer. By directly involving patients in sharing what matters most to them, the survey seeks to provide a more complete and accurate understanding of how cancer and its treatment affect daily life. The results will help patients, families, and healthcare providers better identify needs, guide supportive care, and improve overall well-being throughout the cancer journey.
Sponsor: WellSpan Health · Participants: 1,000 · Started: 2026-02
Contact the study team
- Joan K Moore, MSN, RN, OCN, CCRP · Phone: 717-741-8124
- Rahul Kashyap, MBBS, MBA, FCCM · Phone: 717-851-4611
Official record on ClinicalTrials.gov — NCT07433660
Locations in the U.S.
| Pennsylvania | WellSpan Medical Oncology & Hematology, Chambersburg WellSpan Ephrata Cancer Center, Ephrata WellSpan Adams Cancer Center, Gettysburg WellSpan Sechler Family Cancer Center, Lebanon WellSpan York Cancer Center, York |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.